The supplementation of the diet with astaxanthin could reduce the expression of the peroxisome proliferator-activated receptor gamma (PPARG) and DNA damage inducible-transcript 3 (CHOP-10) genes, thereby diminishing hepatic lipid transport and fatty acid synthesis and avoiding the development of hepatic steatosis [12]. Here, DDIT3 is linked to fatty liver disease.